Cochrane · systematic review · CD009518
Isoflavones for hypercholesterolaemia in adults
Qin, Y, Niu, K, Zeng, Y, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
Metabolic and Endocrine DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
2
No studies
4
Included studies
NR
No studies 4 · 66.7%Ungraded 0 · 0%Very low 1 · 16.7%Low 1 · 16.7%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: postmenopausal women with hypercholesterolaemia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Cardiovascular events | no estimate extracted | NR | No studies |
Death from any cause | no estimate extracted | NR | No studies |
Health‐related quality of life | no estimate extracted | NR | No studies |
Adverse events [ | no estimate extracted | 5 studies · 208 participants | Low Downgraded: risk of bias |
Low‐density lipoprotein (LDL) cholesterol [ | no estimate extracted | 3 studies · 132 participants | Very low Downgraded: risk of bias, indirectness |
Costs | no estimate extracted | NR | No studies |